Biosolution Co., Ltd. logo

Biosolution Co., Ltd. (086820)

Market Open
11 Aug, 02:33
KRX SM KRX SM
6,220. 00
-50
-0.7974%
209.94B Market Cap
- P/E Ratio
- Div Yield
42,893 Volume
- Eps
6,270
Previous Close
Add Transaction
Day Range
6,100 6,480
Year Range
5,240 13,450
Want to track 086820 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

086820 trading today lower at ₩6,220, a decrease of -0.7974% from yesterday's close, completing a monthly decrease of -2.8125% or -₩180. Over the past 12 months, 086820 stock lost -21.8593%.
086820 is not paying dividends to its shareholders.
Biosolution Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 27, 2025.
The company's stock is traded on one exchange.

086820 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

Biosolution Co., Ltd. (086820) FAQ

What is the stock price today?

The current price is ₩6,220.00.

On which exchange is it traded?

Biosolution Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 086820.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 209.94B.

Has Biosolution Co., Ltd. ever had a stock split?

Biosolution Co., Ltd. had 1 splits and the recent split was on May 27, 2025.

Biosolution Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
KR Country
97 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bio Solution Co., Ltd., originally known as MCTT Bio Co., Ltd., is a biotechnology firm that has been leading the field of cell therapy products since its foundation in 2000. With its headquarters based in Seoul, South Korea, the company has garnered global recognition for its innovative endeavors in developing, manufacturing, and distributing a diverse range of cell therapy solutions. In January 2016, in a strategic move to better align its identity with its core mission, the company underwent a rebranding, adopting the name Bio Solution Co., Ltd. This change marked a new chapter in its commitment to addressing complex medical challenges through advanced biotechnological research and products.

Products and Services

  • CartiLife

    An autologous chondrocyte cell-based therapy designed for the repair of articular cartilage defects. CartiLife is aimed at treating symptomatic and structural complications, offering patients a pathway to improved mobility and decreased discomfort.

  • KeraHeal-Allo

    This thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product is engineered to enhance the re-epithelialization process of deep 2nd-degree burns, promoting faster healing and recovery for patients suffering from severe burn wounds.

  • KeraHeal

    An autologous spray-type keratinocyte cell-based therapy tailored for the management of skin wounds. KeraHeal leverages the body's innate healing mechanisms by applying harvested cells directly to the wound site, facilitating natural and effective skin regeneration.

  • Reconstructed Human Micro-Tissue Models

    A sophisticated array of in vitro models, including:

    • KeraSkin: An epidermis model for dermatological research.
    • KeraSkin-FT: A full-thickness skin model that simulates the deeper layers of the skin.
    • KeraSkin-M: A pigmented skin model used for studies on skin pigmentation and its disorders.
    • Corneal Models: For ophthalmological research focusing on the eye's cornea.
    • SoluAirway: An airway mucosa model that simulates the respiratory tract for pulmonary studies.
    • SoluOral: An oral mucosa model designed for dental and oral health research.
    • SoluDPNeuron: A dopaminergic neuron model that aids in the study of neurological conditions such as Parkinson's disease.
    • SoluDANeuron: An islet model for diabetes research, simulating pancreatic functions.
    • SoluLiver: A liver model that provides insights into hepatic processes and diseases.

  • Human-Derived Primary Cell Cultures and Cells

    Bio Solution Co., Ltd. supplies an extensive range of human-derived primary cell cultures and cells for in vitro research purposes, catering to the biomedical research community's need for high-quality biological materials.

  • Bio Advanced Materials

    The company also specializes in the development and provision of bio advanced materials, contributing to the advancement of biotechnological research and therapeutic applications.

  • Cosmetics Raw Materials

    In addition to its biomedical offerings, Bio Solution Co., Ltd. extends its expertise to the cosmetics industry by providing raw materials backed by biotechnological research, enhancing the efficacy and safety of cosmetic products.

Contact Information

Address: Seoul Techno Park
Phone: 82 2 3446 8884